Today we are joined by Dr Debora Barton and our very own Head of Nuclear Medicine, Dr Louise Emmett to dive into the world of radionuclide therapy! We learn about how we can move forward without the old cookie cutter approach, how we can alter the paradigm and create a new force for change in nuclear cancer therapy and imaging. We hear about Full Life Therapeutics’ radio ligand discovery platform and in-house actinium production capabilities.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör NSW Early Phase Clinical Trials Alliance (NECTA). Innehållet i podden är skapat av NSW Early Phase Clinical Trials Alliance (NECTA) och inte av, eller tillsammans med, Poddtoppen.